Columbus Circle Investors’s Gilead Sciences GILD Stock Holding History

Columbus Circle Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,652,895	Closed	-$138M	–	282
2016 Q2	$138M	Sell	1,652,895 -1,544,943	-48%	-$137M	1.38%	17
2016 Q1	$294M	Sell	3,197,838 -28,893	-0.9%	-$2.61M	2.62%	4
2015 Q4	$327M	Sell	3,226,731 -247,482	-7%	-$25.8M	2.62%	2
2015 Q3	$341M	Sell	3,474,213 -88,337	-2%	-$9.81M	2.79%	2
2015 Q2	$417M	Sell	3,562,550 -605,656	-15%	-$66.2M	2.95%	2
2015 Q1	$409M	Sell	4,168,206 -2,109	-0.1%	-$214K	2.78%	2
2014 Q4	$393M	Buy	4,170,315 +49,163	+1%	+$5.08M	2.78%	2
2014 Q3	$439M	Sell	4,121,152 -689,614	-14%	-$67.5M	3.15%	2
2014 Q2	$399M	Sell	4,810,766 -304,123	-6%	-$23.7M	2.73%	3
2014 Q1	$362M	Sell	5,114,889 -75,758	-1%	-$5.94M	2.41%	3
2013 Q4	$390M	Buy	5,190,647 +68,714	+1%	+$4.78M	2.66%	2
2013 Q3	$322M	Sell	5,121,933 -734,697	-13%	-$43.9M	2.28%	2
2013 Q2	$300M	Buy	+5,856,630	New	+$305M	2.41%	3

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Columbus Circle Investors's GILD Position: Q3 2016 in Review

Columbus Circle Investors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 1,652,895 shares — an estimated $138M sold.

Columbus Circle Investors first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $439M in Q3 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Columbus Circle Investors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Columbus Circle Investors sold 1,652,895 Gilead Sciences shares in Q3 2016, an estimated $138M.
Columbus Circle Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
Columbus Circle Investors's Gilead Sciences position peaked at $439M in Q3 2014.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Columbus Circle Investors's 13F filing for Q3 2016, filed 10 Nov 2016.